258 related articles for article (PubMed ID: 34503295)
1. MYC Rules: Leading Glutamine Metabolism toward a Distinct Cancer Cell Phenotype.
Tambay V; Raymond VA; Bilodeau M
Cancers (Basel); 2021 Sep; 13(17):. PubMed ID: 34503295
[TBL] [Abstract][Full Text] [Related]
2. Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression.
Xu X; Li J; Sun X; Guo Y; Chu D; Wei L; Li X; Yang G; Liu X; Yao L; Zhang J; Shen L
Oncotarget; 2015 Sep; 6(28):26161-76. PubMed ID: 26317652
[TBL] [Abstract][Full Text] [Related]
3. Inhibitor of differentiation 1 transcription factor promotes metabolic reprogramming in hepatocellular carcinoma cells.
Sharma BK; Kolhe R; Black SM; Keller JR; Mivechi NF; Satyanarayana A
FASEB J; 2016 Jan; 30(1):262-75. PubMed ID: 26330493
[TBL] [Abstract][Full Text] [Related]
4. Impact of MYC in regulation of tumor cell metabolism.
Wahlström T; Henriksson MA
Biochim Biophys Acta; 2015 May; 1849(5):563-9. PubMed ID: 25038584
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs and oncogenic transcriptional regulatory networks controlling metabolic reprogramming in cancers.
Pinweha P; Rattanapornsompong K; Charoensawan V; Jitrapakdee S
Comput Struct Biotechnol J; 2016; 14():223-33. PubMed ID: 27358718
[TBL] [Abstract][Full Text] [Related]
6. MYC and metabolism on the path to cancer.
Hsieh AL; Walton ZE; Altman BJ; Stine ZE; Dang CV
Semin Cell Dev Biol; 2015 Jul; 43():11-21. PubMed ID: 26277543
[TBL] [Abstract][Full Text] [Related]
7.
Camarda R; Williams J; Goga A
Front Cell Dev Biol; 2017; 5():35. PubMed ID: 28443280
[TBL] [Abstract][Full Text] [Related]
8. Oncogene-Driven Metabolic Alterations in Cancer.
Min HY; Lee HY
Biomol Ther (Seoul); 2018 Jan; 26(1):45-56. PubMed ID: 29212306
[TBL] [Abstract][Full Text] [Related]
9. MYC and tumor metabolism: chicken and egg.
Dejure FR; Eilers M
EMBO J; 2017 Dec; 36(23):3409-3420. PubMed ID: 29127156
[TBL] [Abstract][Full Text] [Related]
10. Interplay between MycN and c-Myc regulates radioresistance and cancer stem cell phenotype in neuroblastoma upon glutamine deprivation.
Le Grand M; Mukha A; Püschel J; Valli E; Kamili A; Vittorio O; Dubrovska A; Kavallaris M
Theranostics; 2020; 10(14):6411-6429. PubMed ID: 32483461
[TBL] [Abstract][Full Text] [Related]
11. Glutaminolysis: A Hallmark of Cancer Metabolism.
Yang L; Venneti S; Nagrath D
Annu Rev Biomed Eng; 2017 Jun; 19():163-194. PubMed ID: 28301735
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial p32 is upregulated in Myc expressing brain cancers and mediates glutamine addiction.
Fogal V; Babic I; Chao Y; Pastorino S; Mukthavaram R; Jiang P; Cho YJ; Pingle SC; Crawford JR; Piccioni DE; Kesari S
Oncotarget; 2015 Jan; 6(2):1157-70. PubMed ID: 25528767
[TBL] [Abstract][Full Text] [Related]
13. Glutamine Addiction In Gliomas.
Márquez J; Alonso FJ; Matés JM; Segura JA; Martín-Rufián M; Campos-Sandoval JA
Neurochem Res; 2017 Jun; 42(6):1735-1746. PubMed ID: 28281102
[TBL] [Abstract][Full Text] [Related]
14. c-Myc-driven glycolysis via TXNIP suppression is dependent on glutaminase-MondoA axis in prostate cancer.
Qu X; Sun J; Zhang Y; Li J; Hu J; Li K; Gao L; Shen L
Biochem Biophys Res Commun; 2018 Oct; 504(2):415-421. PubMed ID: 30103944
[TBL] [Abstract][Full Text] [Related]
15. N-Myc-induced metabolic rewiring creates novel therapeutic vulnerabilities in neuroblastoma.
Tjaden B; Baum K; Marquardt V; Simon M; Trajkovic-Arsic M; Kouril T; Siebers B; Lisec J; Siveke JT; Schulte JH; Benary U; Remke M; Wolf J; Schramm A
Sci Rep; 2020 Apr; 10(1):7157. PubMed ID: 32346009
[TBL] [Abstract][Full Text] [Related]
16. Glutamine stabilizes myc via alpha-ketoglutarate and regulates paclitaxel sensitivity.
Bhardwaj V; He J; Jain A
Med Oncol; 2022 Sep; 39(12):227. PubMed ID: 36175776
[TBL] [Abstract][Full Text] [Related]
17. Lactate promotes glutamine uptake and metabolism in oxidative cancer cells.
Pérez-Escuredo J; Dadhich RK; Dhup S; Cacace A; Van Hée VF; De Saedeleer CJ; Sboarina M; Rodriguez F; Fontenille MJ; Brisson L; Porporato PE; Sonveaux P
Cell Cycle; 2016; 15(1):72-83. PubMed ID: 26636483
[TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of how Myc controls T cell proteomes and metabolic pathways during T cell activation.
Marchingo JM; Sinclair LV; Howden AJ; Cantrell DA
Elife; 2020 Feb; 9():. PubMed ID: 32022686
[TBL] [Abstract][Full Text] [Related]
19. Metabolic reprogramming in cancer cells: glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer.
Li C; Zhang G; Zhao L; Ma Z; Chen H
World J Surg Oncol; 2016 Jan; 14(1):15. PubMed ID: 26791262
[TBL] [Abstract][Full Text] [Related]
20. Myc requires RhoA/SRF to reprogram glutamine metabolism.
Haikala HM; Marques E; Turunen M; Klefström J
Small GTPases; 2018 May; 9(3):274-282. PubMed ID: 27532209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
